StockData
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. (RLAY) stock

RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$16.51+0.04 (+0.24%)

Close on Nov 18, 2026Market cap $3.62BP/E –Yield –

Relay Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Relay Therapeutics's price to sales ratio was 416.4× on Nov 11, 2026, against 163.6× a year earlier. Over the last 2 years it ranged from 37.8× to 416.4×, with a median of 116.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026416.4×+241.6
2025Dec 31, 2025174.8×+130.6
2024Jan 31, 202444.2×−8.4
2023Dec 29, 202352.6×–

More Relay Therapeutics figures

See a number that looks wrong?